NRC Health Lease Obligation Incurred
NRC Health (NRC) reported Lease Obligation Incurred of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2024-02-27
- NRC Health lease obligation incurred for the quarter ending 2021-12-31 was $40.00K, a 13.04% decline year-over-year.
- NRC Health lease obligation incurred for the quarter ending 2020-12-31 was $46.00K.
- NRC Health lease obligation incurred for the quarter ending 2020-09-30 was $666.00K, a 1607.69% increase year-over-year.
- NRC Health lease obligation incurred for the quarter ending 2019-12-31 was -$14.00K.
- NRC Health lease obligation incurred for fiscal 2023 was $0.00.
- NRC Health lease obligation incurred for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- NRC Health lease obligation incurred for fiscal 2021 was $40.00K, a 95.10% decline from fiscal 2020.
- NRC Health lease obligation incurred for fiscal 2020 was $817.00K, a 325.52% increase from fiscal 2019.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-27 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-27 | |||
| 2021-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $40.00K 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | |||
| 2020-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $712.00K derived: sum of 2 quarters · filed 2023-03-03 | $817.00K 10-K · filed 2023-03-03 | |
| 2020-09-30 | $666.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $771.00K 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $105.00K 10-Q · filed 2021-08-06 | |||
| 2019-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $25.00K derived: sum of 2 quarters · filed 2022-03-04 | $167.00K derived: sum of 3 quarters · filed 2022-03-04 | $192.00K 10-K · filed 2022-03-04 |
| 2019-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $181.00K derived: sum of 2 quarters · filed 2020-11-06 | $206.00K 10-Q · filed 2020-11-06 | $206.00K derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-06-30 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $167.00K 10-Q · filed 2020-08-07 | $167.00K derived: sum of 3 quarters · filed 2021-03-05 | $836.00K derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-03-31 | $25.00K 10-Q · filed 2020-05-08 | $25.00K derived: sum of 2 quarters · filed 2021-03-05 | $694.00K derived: sum of 3 quarters · filed 2021-03-05 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $669.00K derived: sum of 2 quarters · filed 2021-03-05 | $879.00K 10-K · filed 2021-03-05 | |
| 2018-09-30 | $669.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $879.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $210.00K 10-Q · filed 2019-08-08 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $10.00K derived: sum of 2 quarters · filed 2020-03-06 | $10.00K derived: sum of 3 quarters · filed 2020-03-06 | $74.00K 10-K · filed 2020-03-06 |
| 2017-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $10.00K derived: sum of 2 quarters · filed 2018-11-08 | $74.00K 10-Q · filed 2018-11-08 | $74.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $64.00K 10-Q · filed 2018-08-09 | $64.00K derived: sum of 3 quarters · filed 2019-03-08 | $64.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $64.00K 10-Q · filed 2018-05-04 | $64.00K derived: sum of 2 quarters · filed 2019-03-08 | $64.00K derived: sum of 3 quarters · filed 2019-03-08 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | $109.00K 10-K · filed 2019-03-08 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $109.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $109.00K 10-Q · filed 2017-08-04 | |||
| 2015-12-31 | $32.00K 10-K · filed 2018-03-14 | |||
| 2014-12-31 | $248.00K 10-K · filed 2017-03-03 | |||
| 2013-12-31 | $5.00K 10-K · filed 2016-03-04 | |||
| 2012-12-31 | $9.00K 10-K · filed 2015-03-04 | |||
| 2011-12-31 | $115.00K 10-K · filed 2014-03-04 | |||
| 2010-12-31 | $389.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |